Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
MEIP MEI Pharma Inc
- Stocks
- Healthcare
- NASDAQ: MEIP
Price (delayed)
$2.08
Market cap
$13.86M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$5.73
Enterprise value
-$9.88M
MEI Pharma, Inc. is a late-stage pharmaceutical company focused on developing potential new therapies for cancer. MEI Pharma's portfolio of drug candidates contains four clinical-stage assets, including zandelisib, currently in
Highlights
MEI Pharma's debt has shrunk by 100% YoY
The company's quick ratio rose by 40% YoY and by 11% QoQ
MEI Pharma's gross profit has shrunk by 100% YoY
MEIP's revenue has shrunk by 100% YoY
Key stats
What are the main financial stats of MEIP
Market
Valuations
Earnings
Shares outstanding
6.66M
Market cap
$13.86M
Enterprise value
-$9.88M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.63
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$40.61M
Net income
-$38.22M
EBIT
-$38.22M
EBITDA
-$35.74M
Free cash flow
-$36.03M
Per share
Balance sheet
Liquidity
EPS
-$5.73
EPS diluted
-$5.73
Free cash flow per share
-$5.41
Book value per share
$3.32
Revenue per share
$0
TBVPS
$3.66
Total assets
$24.39M
Total liabilities
$2.29M
Debt
$0
Equity
$22.1M
Working capital
$22.1M
Debt to equity
0
Current ratio
10.66
Quick ratio
10.38
Net debt/EBITDA
0.66
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-92.8%
Return on equity
-116.7%
Return on invested capital
-131.2%
Return on capital employed
-172.9%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MEIP stock price
How has the MEI Pharma stock price performed over time
Intraday
1.46%
1 week
1.46%
1 month
11.83%
1 year
-34.18%
YTD
-15.45%
QTD
-5.02%
Financial performance
How have MEI Pharma's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$40.61M
Net income
-$38.22M
Gross margin
N/A
Net margin
N/A
MEI Pharma's gross profit has shrunk by 100% YoY
MEIP's revenue has shrunk by 100% YoY
MEIP's net income is up by 18% since the previous quarter
The operating income has grown by 17% from the previous quarter
Price vs fundamentals
How does MEIP's price correlate with its fundamentals
Growth
What is MEI Pharma's growth rate over time
Valuation
What is MEI Pharma stock price valuation
P/E
N/A
P/B
0.63
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 18% from the previous quarter
The stock's price to book (P/B) is 78% less than its 5-year quarterly average of 2.8 and 10% less than its last 4 quarters average of 0.7
The equity has shrunk by 63% YoY and by 11% QoQ
MEIP's revenue has shrunk by 100% YoY
Efficiency
How efficient is MEI Pharma business performance
MEI Pharma's ROIC has decreased by 38% from the previous quarter
MEIP's return on assets is down by 9% since the previous quarter
The ROE fell by 5% QoQ
Dividends
What is MEIP's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did MEI Pharma financials performed over time
The total liabilities has plunged by 88% YoY and by 20% from the previous quarter
The total assets has dropped by 69% year-on-year and by 12% since the previous quarter
MEI Pharma's debt is 100% lower than its equity
MEI Pharma's debt has shrunk by 100% YoY
MEI Pharma's debt to equity has shrunk by 100% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.